Hemant Surgical Industries Limited (BOM:543916)
India · Delayed Price · Currency is INR 383.95
+4.55 (1.20%)
At close: Jun 22, 2026
BOM:543916 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,318 | 1,066 | 1,056 | 1,091 | 1,036 |
Other Revenue | - | 0 | - | - | - |
| 2,318 | 1,066 | 1,056 | 1,091 | 1,036 | |
Revenue Growth (YoY) | 117.38% | 0.97% | -3.24% | 5.39% | 73.30% |
Cost of Revenue | 1,786 | 765.6 | 782.48 | 815.55 | 824.29 |
Gross Profit | 532.54 | 300.77 | 273.6 | 275.93 | 211.41 |
Selling, General & Admin | 100.91 | 111.71 | 120.64 | 111.15 | 79.68 |
Other Operating Expenses | 140.75 | 86.42 | 48.25 | 59.08 | 68.74 |
Operating Expenses | 257.02 | 212.38 | 179.15 | 178.73 | 155.91 |
Operating Income | 275.52 | 88.39 | 94.45 | 97.2 | 55.51 |
Interest Expense | -39.66 | -22.73 | -9.45 | -16.87 | -16.08 |
Interest & Investment Income | - | 5.92 | 11.21 | 5.24 | 1.24 |
Currency Exchange Gain (Loss) | - | 1.4 | 13.56 | 14.74 | 4.91 |
Other Non Operating Income (Expenses) | -0 | 13.51 | 8.69 | 0.49 | 2.91 |
EBT Excluding Unusual Items | 235.87 | 86.49 | 118.46 | 100.8 | 48.48 |
Gain (Loss) on Sale of Assets | - | 1.78 | - | -0.23 | - |
Other Unusual Items | - | -11.65 | - | - | - |
Pretax Income | 235.87 | 104.66 | 127.81 | 100.57 | 61.12 |
Income Tax Expense | 53.96 | 24.25 | 29.81 | 24.2 | 14.98 |
Net Income | 181.91 | 80.41 | 98 | 76.37 | 46.14 |
Net Income to Common | 181.91 | 80.41 | 98 | 76.37 | 46.14 |
Net Income Growth | 126.23% | -17.95% | 28.32% | 65.52% | 302.86% |
Shares Outstanding (Basic) | 12 | 10 | 10 | 7 | 5 |
Shares Outstanding (Diluted) | 12 | 10 | 10 | 7 | 5 |
Shares Change (YoY) | 16.63% | 4.93% | 33.66% | 44.60% | - |
EPS (Basic) | 15.39 | 7.70 | 9.85 | 10.26 | 8.96 |
EPS (Diluted) | 14.94 | 7.70 | 9.85 | 10.26 | 8.96 |
EPS Growth | 94.03% | -21.82% | -4.00% | 14.50% | 303.60% |
Free Cash Flow | -341.72 | -287.33 | -130.8 | 23.69 | 116.41 |
Free Cash Flow Per Share | -28.07 | -27.52 | -13.15 | 3.18 | 22.61 |
Gross Margin | 22.97% | 28.21% | 25.91% | 25.28% | 20.41% |
Operating Margin | 11.89% | 8.29% | 8.94% | 8.91% | 5.36% |
Profit Margin | 7.85% | 7.54% | 9.28% | 7.00% | 4.46% |
Free Cash Flow Margin | -14.74% | -26.95% | -12.38% | 2.17% | 11.24% |
EBITDA | 290.88 | 102.64 | 104.71 | 105.7 | 62.99 |
EBITDA Margin | 12.55% | 9.63% | 9.92% | 9.68% | 6.08% |
D&A For EBITDA | 15.36 | 14.26 | 10.26 | 8.5 | 7.49 |
EBIT | 275.52 | 88.39 | 94.45 | 97.2 | 55.51 |
EBIT Margin | 11.89% | 8.29% | 8.94% | 8.91% | 5.36% |
Effective Tax Rate | 22.88% | 23.17% | 23.33% | 24.06% | 24.51% |
Revenue as Reported | 2,377 | 1,118 | 1,099 | 1,115 | 1,058 |
Advertising Expenses | - | 4.72 | 5.75 | 9.89 | 2.01 |